We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.91B
1-Year Est. Return 44.39%
This Fund
S&P 500
This Quarter Est. Return
-2.29%
1 Year Est. Return
+44.39%
3 Year Est. Return
+110.36%
5 Year Est. Return
+52.4%
10 Year Est. Return
+1,142.23%
AUM
$524M
AUM Growth
-$65.4M
Cap. Flow
-$51.4M
Cap. Flow %
-9.8%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
2
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
LCTX icon
Lineage Cell Therapeutics
LCTX
+$7.21M
2
IMDX
Insight Molecular Diagnostics
IMDX
+$2.45M

Top Sells

Rank Stock Value
1
CYNO
Cynosure, Inc. Class A
CYNO
+$61.1M

Sector Composition

Rank Sector Weight
1 Healthcare 46.73%
2 Consumer Staples 42.23%
3 Miscellaneous 11.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNST icon
1
Monster Beverage
MNST
$87.5B
$221M 42.23%
19,189,632
– –
STAA icon
2
STAAR Surgical
STAA
$1.14B
$106M 20.28%
10,855,179
– –
LCTX icon
3
Lineage Cell Therapeutics
LCTX
$263M
$93.6M 17.84%
30,997,307
+2,539,999
+9% +$7.21M
IWM icon
4
iShares Russell 2000 ETF
IWM
$76.1B
$57.7M 11.01%
420,000
– –
IMDX
5
Insight Molecular Diagnostics
IMDX
$118M
$18.2M 3.47%
152,834
+21,250
+16% +$2.45M
MNK
6
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$14.4M 2.74%
322,411
– –
AST
7
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$12.6M 2.4%
3,699,848
– –
AST.WS
8
DELISTED
Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017)
AST.WS
$140K 0.03%
328,205
– –
CYNO
9
DELISTED
Cynosure, Inc. Class A
CYNO
– –
-1,338,827
Closed -$61.1M

Similar funds

EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.91B AUM 19.99% 1-Year Est. Return
RMA
Roffman Miller Associates Philadelphia, Pennsylvania $1.91B AUM 28.29% 1-Year Est. Return
LWMT
Legacy Wealth Management (Tennessee) Memphis, Tennessee $1.91B AUM 17.42% 1-Year Est. Return
FIB
First Interstate Bank Billings, Montana $1.92B AUM 19.65% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $1.92B AUM 6.41% 1-Year Est. Return
HPC
Hill Path Capital New York $1.92B AUM 5.67% 1-Year Est. Return
R
Rebalance Palo Alto, California $1.91B AUM 16.23% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Broadwood Capital's Q1 2017 Portfolio in Review

As of Q1 2017, Broadwood Capital held 9 positions worth $524M, down 11% from $590M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital withdrew a net $51.4M in Q1 2017, closing 1 position. Its most notable exit was Cynosure, Inc. Class A, an estimated $61.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 54% a quarter earlier, followed by Consumer Staples and Miscellaneous.

Against the trend, Broadwood Capital added an estimated $7.21M to Lineage Cell Therapeutics.

  • Broadwood Capital added most to Lineage Cell Therapeutics in Q1 2017, an estimated $7.21M increase.
  • Broadwood Capital fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $61.1M.
  • Broadwood Capital's ten largest holdings make up 100% of its $524M portfolio in Q1 2017.
  • Broadwood Capital opened 0 new positions and closed 1 in Q1 2017.
  • Broadwood Capital's portfolio value fell 11% quarter-over-quarter to $524M.

Based on Broadwood Capital's 13F filing for Q1 2017, filed 15 May 2017.